4726
L. Xie et al. / Tetrahedron: Asymmetry 10 (1999) 4715–4728
4.2. (±)-2-Phenyl-4-benzyl-5(4H)-oxazolone 1
Compound 1 was prepared from N-benzoyl-phenylalanine according to literature procedure.2a Yield
80%; mp: 66–68°C (lit.:2a mp: 70–71°C). IR (cm−1): 1812, 1754. 1H NMR (ppm, CDCl3): δ 3.20 (dd,
1H, J=6.4, 14 Hz), 3.40 (dd, 1H, J=5.2, 14 Hz), 4.71 (dd, 1H, J=5.2, 6.4 Hz), 7.22–7.29 (m, 5H), 7.44
(m, 2H), 7.55 (m, 1H), 7.94 (m, 2H).
4.3. N-Tosyl-(S)-prolyl-(S)-histidine methyl ester 4
(S)-Histidine methyl ester dihydrochloride (100 mg) was suspended in CHCl3 (1.5 mL) and Et3N
(0.125 mL) was added. The mixture was stirred and cooled in an ice–salt bath (−5°C). A solution of
N-tosyl-(S)-prolyl chloride14 (120 mg) in CHCl3 (5 mL) was added dropwise and Et3N (0.06 mL) was
added again. The mixture was stirred overnight. CHCl3 (5 mL) was added and the reaction mixture was
extracted with water then with aqueous ammonia (0.05 mol dm−3) and finally with water. The organic
layer was dried over anhydrous MgSO4 and concentrated in vacuum to give 170 mg of 4 as an oily solid.
Crystallization from benzene–petroleum ether (30–60°C) gave 110 mg (yield 63.4%) of white solid; mp:
57.5–59.5°C. IR (cm−l): 3399, 2955, 1745, 1672, 1347, 1160, and 1092. 1H NMR (ppm, CDCl3): δ 1.6
(m, 1H), 1.70 (m, 1H), 1.86 (m, 1H), 2.03 (m, 1H), 2.44 (s, 3H), 3.13–3.27 (m, 3H), 3.62 (m, 1H), 3.75
(s, 3H), 4.31 (dd, 1H, J=3.1, 8.7 Hz), 4.80 (m, 1H), 6.98 (s, 1H), 7.36 (s, 1H), 7.37 (d, 2H, J=8.1 Hz),
7.69 (s, 1H), 7.86 (d, 2H, J=8.2 Hz), 8.54 (d, 1H, J=8 Hz). FABMS 421 [M+H]+.
4.4. Benzyloxycarbonyl-(S)-alanyl-(S)-histidine methyl ester 5
Compound 5 was prepared from benzyloxycarbonyl-(S)-alanine-p-nitrophenyl ester and (S)-histidine
methyl ester dihydrochloride according to the literature.15 Yield 53%; mp: 164–166 (lit.:9c mp: 168–169).
1
IR (cm−1): 3379, 3248, 2990, 2852, 1732, 1702, 1649, 1566, 1505, 1456, 1379, 1340, 1291, 1235. H
NMR (ppm, CDCl3): δ 1.41 (d, 3H, J=7.2 Hz), 3.19 (m, 2H), 3.74 (s, 3H), 4.25 (dq, 1H, J=6.8, 7 Hz),
4.80 (m, 1H), 5.09 (d, 1H, J=12.4 Hz), 5.13 (d, 1H, J=12.2 Hz), 5.53 (d, 1H, J=6.4 Hz), 6.82 (s, 1H), 7.33
(m, 6H), 7.7 (s, 1H).
4.5. Benzyloxycarbonyl-(S)-phenylalanyl-(S)-histidine methyl ester 6
Compound 6 was prepared from benzyloxycarbonyl-(S)-phenylalanine-p-nitrophenyl ester and (S)-
histidine methyl ester dihydrochloride according to the literature.15 Yield 76%; mp: 128–138°C (lit.:15
yield 39%; mp: 146–154°C; lit.:9c yield 77%; mp: 114–116°C). IR (cm−1): 3312, 3013, 2952, 2854,
1743, 1699, 1648, 1532, 1440, 1391, 1256, 1215. 1H NMR (ppm, CDCl3): δ 2.95–3.15 (m, 4H), 3.68 (s,
3H), 4.39 (m, 1H), 4.75 (m, 1H), 5.07 (s, 2H), 5.43 (d, 1H, J=7.2 Hz), 6.72 (s, 1H), 7.18 (m, 11H, ArH
and CONH), 7.47 (s, 1H), 8.1 (bs, 1H).
4.6. (3S,6S)-3-(4-Imidazolylmethyl)-6-methylpiperazine-2,5-dione 7
Compound 7 was prepared from 5 according to the literature.15 Yield 79%; mp: 224–235°C (lit.:9c mp:
245–250°C). IR (cm−1): 3320, 3127, 2982, 2840, 1664, 1423, and 1312. 1H NMR (ppm, (CD3)2SO): δ
1.16 (d, 3H, J=7.2 Hz), 3.08 (m, 2H), 3.90 (q, 1H, J=6.9 Hz), 4.24 (t, 1H, J=5.42 Hz), 7.34 (s, 1H), 8.12
(s, 1H), 8.27 (s, 1H), 8.93 (s, 1H), 14.16 (bs, 2H).